tiprankstipranks
Biosyent Inc (TSE:RX)
:RX
Canadian Market
RX
Biosyent
RESEARCH TOOLSreports

Biosyent (RX) Financial Statements

54 Followers

Biosyent Financial Overview

Biosyent's market cap is currently C$170.16M. The company's EPS TTM is C$0.17; its P/E ratio is 15.91; and it has a dividend yield of 1.60%. Biosyent is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 43.05MC$ 35.03MC$ 31.59MC$ 27.93MC$ 28.62M
Gross ProfitC$ 32.11MC$ 27.86MC$ 25.60MC$ 22.86MC$ 22.64M
Operating IncomeC$ 11.31MC$ 8.75MC$ 7.47MC$ 6.98MC$ 8.18M
EBITDAC$ 12.17MC$ 10.43MC$ 9.06MC$ 7.43MC$ 8.64M
Net IncomeC$ 9.01MC$ 7.27MC$ 6.46MC$ 5.46MC$ 6.28M
Balance Sheet
Cash & Short-Term InvestmentsC$ 28.65MC$ 15.94MC$ 26.19MC$ 28.70MC$ 28.21M
Total AssetsC$ 49.44MC$ 41.36MC$ 41.53MC$ 40.49MC$ 37.17M
Total DebtC$ 841.10KC$ 1.04MC$ 1.22MC$ 1.40MC$ 1.56M
Net DebtC$ -19.44MC$ -11.08MC$ -6.76MC$ -6.47MC$ -16.48M
Total LiabilitiesC$ 7.97MC$ 6.36MC$ 6.77MC$ 7.12MC$ 5.61M
Stockholders' EquityC$ 41.47MC$ 35.00MC$ 34.76MC$ 33.36MC$ 31.55M
Cash Flow
Free Cash FlowC$ 9.57MC$ 3.99MC$ 4.88MC$ 4.43MC$ 4.58M
Operating Cash FlowC$ 9.62MC$ 8.66MC$ 5.05MC$ 4.95MC$ 4.67M
Investing Cash FlowC$ 3.48MC$ 3.29MC$ 883.85KC$ -10.79MC$ -4.84M
Financing Cash FlowC$ -3.41MC$ -7.83MC$ -5.78MC$ -4.37MC$ -2.08M
Currency in CAD

Biosyent Earnings and Revenue History

Income Statement >

Biosyent Debt to Assets

Balance Sheet >

Biosyent Cash Flow

Cash Flow >

Biosyent Forecast EPS vs Actual EPS

Earnings >